6533b83afe1ef96bd12a7615
RESEARCH PRODUCT
Distinct biological effects are observed in HT-29 colorectal carcinoma cells induced to express K-RASG12V or K-RASG13D
Maria Magdalena BarrecaM. R. SaladinoI. Albanesesubject
KRAS Colorectal carcinoma Cetuximab| year | journal | country | edition | language | 
|---|---|---|---|---|
| 2015-01-01 |